We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.95%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$94.8B
AUM Growth
-$8.26B
(-8%)
Cap. Flow
-$2.48B
Cap. Flow
% of AUM
-2.61%
Top 10 Holdings %
Top 10 Hldgs %
21.55%
Holding
2,181
New
100
Increased
1,075
Reduced
690
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$671M |
| 2 |
Broadcom
AVGO
|
+$416M |
| 3 |
ServiceNow
NOW
|
+$264M |
| 4 |
Arista Networks
ANET
|
+$262M |
| 5 |
Autodesk
ADSK
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$284M |
| 2 |
Microsoft
MSFT
|
+$281M |
| 3 |
Micron Technology
MU
|
+$275M |
| 4 |
Teradyne
TER
|
+$274M |
| 5 |
KLA
KLAC
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.64% |
| 2 | Industrials | 14.32% |
| 3 | Healthcare | 12.96% |
| 4 | Financials | 7.97% |
| 5 | Utilities | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Enliven Therapeutics
ELVN
$4.31B
| $36.4M | 0.04% |
929,544
-373,691
| -29% | -$10.4M |
|
377
Canadian Imperial Bank of Commerce
CM
$109B
| $35.8M | 0.04% |
379,527
-19,820
| -5% | -$1.89M |
|
378
Brookfield
BN
$110B
| $34.5M | 0.04% |
853,730
-19,964
| -2% | -$885K |
|
379
Viatris
VTRS
$18.7B
| $34.4M | 0.04% |
2,645,328
+285,217
| +12% | +$3.99M |
|
380
Sherwin-Williams
SHW
$88.5B
| $34.2M | 0.04% |
106,595
-32,885
| -24% | -$11.3M |
|
381
Ferrovial N.V. Ordinary Shares
FER
$47.3B
| $34.1M | 0.04% |
538,895
+15,285
| +3% | +$1.03M |
|
382
FedEx
FDX
$76.3B
| $34M | 0.04% |
95,477
+5,345
| +6% | +$1.86M |
|
383
Schwab US TIPS ETF
SCHP
$16.2B
| $33.7M | 0.04% |
1,267,000
+1,199,060
| +1,765% | +$32M |
|
384
Aflac
AFL
$60.7B
| $33.6M | 0.04% |
306,702
-30,527
| -9% | -$3.38M |
|
385
Emerson Electric
EMR
$91.7B
| $33.6M | 0.04% |
256,438
-6,557
| -2% | -$943K |
|
386
Truist Financial
TFC
$63.9B
| $33.6M | 0.04% |
730,463
-95,932
| -12% | -$4.74M |
|
387
Cencora
COR
$63.7B
| $33.6M | 0.04% |
106,893
-1,056
| -1% | -$369K |
|
388
Canadian Natural Resources
CNQ
$98.1B
| $33.5M | 0.04% |
688,249
-18,083
| -3% | -$744K |
|
389
Moderna
MRNA
$24.2B
| $32.8M | 0.03% |
676,117
-61,977
| -8% | -$2.89M |
|
390
Warner Bros
WBD
$67.9B
| $32.6M | 0.03% |
1,187,245
-25,228
| -2% | -$706K |
|
391
Sonoco
SON
$5.71B
| $32.6M | 0.03% |
601,871
-57,257
| -9% | -$2.95M |
|
392
Mondelez International
MDLZ
$78.9B
| $32.6M | 0.03% |
564,762
-85,677
| -13% | -$4.96M |
|
393
Royal Caribbean
RCL
$82.1B
| $32.3M | 0.03% |
117,657
-12,346
| -9% | -$3.68M |
|
394
Illumina
ILMN
$29.1B
| $32.3M | 0.03% |
266,153
-36,199
| -12% | -$4.75M |
|
395
Jazz Pharmaceuticals
JAZZ
$16.1B
| $31.8M | 0.03% |
173,250
-11,446
| -6% | -$2M |
|
396
Sanofi
SNY
$104B
| $31.7M | 0.03% |
678,092
+54,081
| +9% | +$2.52M |
|
397
Gulfport Energy Corp
GPOR
$3.03B
| $31.7M | 0.03% |
149,652
-15,605
| -9% | -$3.1M |
|
398
Oneok
OKE
$57.7B
| $31.6M | 0.03% |
349,261
-34,789
| -9% | -$2.86M |
|
399
Target
TGT
$69.2B
| $31.5M | 0.03% |
260,014
+1,154
| +0.4% | +$130K |
|
400
Ross Stores
ROST
$80.8B
| $31.2M | 0.03% |
144,040
-2,900
| -2% | -$578K |
|
Similar funds
Pictet Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Pictet Asset Management held 2,181 positions worth $94.8B, down 8% from $103B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Pictet Asset Management's Q1 2026 filing shows 100 new, 1,075 increased, 690 reduced and 79 closed positions. Its largest new stake was AstraZeneca: 3,481,864 shares worth $675M. The largest sale was Lam Research, an estimated $284M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 35% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q1 2026 buy was AstraZeneca: 3,481,864 shares worth $675M.
- Pictet Asset Management added most to Broadcom in Q1 2026, an estimated $416M increase.
- Pictet Asset Management's biggest Q1 2026 reduction was Lam Research, cutting an estimated $284M.
- Pictet Asset Management fully exited CyberArk in Q1 2026, selling an estimated $104M.
- Pictet Asset Management's ten largest holdings make up 22% of its $94.8B portfolio in Q1 2026.
- Pictet Asset Management opened 100 new positions and closed 79 in Q1 2026.
- Pictet Asset Management's portfolio value fell 8% quarter-over-quarter to $94.8B.
Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.